Maternus-Kliniken AG (HAM:MAK) Buyback Yield %: 0.00 (As of Jul. 08, 2026)


HAM:MAK Maternus-Kliniken AG HAM:MAK
41 GF Score
Price €0.96
GF Value €1.75
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Maternus-Kliniken AG Buyback Yield %?

Maternus-Kliniken AG HAM:MAK +11.05% 41 Buyback Yield % is 0.00 as of Jul. 08, 2026. GuruFocus rates HAM:MAK with a GF Score™ of 41/100 and a GF Value™ of €1.75 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 276 Healthcare Providers & Services companies, Maternus-Kliniken AG ranks worse than 362318.48% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Maternus-Kliniken AG's current buyback yield was 0.00%.

Maternus-Kliniken AG Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Maternus-Kliniken AG's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maternus-Kliniken AG Buyback Yield % Chart

Maternus-Kliniken AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Maternus-Kliniken AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

HAM:MAK vs HCA, THC, DVA: Buyback Yield % Comparison

For the Medical Care Facilities subindustry, Maternus-Kliniken AG's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Maternus-Kliniken AG Buyback Yield % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Maternus-Kliniken AG's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Maternus-Kliniken AG's Buyback Yield % falls into.


HAM:MAK
41GF Score
Maternus-Kliniken AG HAM:MAK
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maternus-Kliniken AG Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Maternus-Kliniken AG's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 19.0827
=0.00%

Maternus-Kliniken AG's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 19.0827
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
Maternus-Kliniken AG (HAM:MAK) has a Buyback Yield % of 0.00 as of Jul. 08, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Maternus-Kliniken AG and its competitors. According to the industry distribution chart, Maternus-Kliniken AG ranks #999999 out of 276 companies in the Healthcare Providers & Services industry.
Is Maternus-Kliniken AG's Buyback Yield % too high?
Maternus-Kliniken AG's current Buyback Yield % is 0.00. Based on the distribution chart, Maternus-Kliniken AG ranks #999999 out of 276 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Maternus-Kliniken AG has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Maternus-Kliniken AG's Buyback Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Maternus-Kliniken AG ranks #999999 out of 276 companies for Buyback Yield %. This places Maternus-Kliniken AG in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Maternus-Kliniken AG and its competitors. Maternus-Kliniken AG's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maternus-Kliniken AG stock overvalued right now?
Based on GuruFocus' analysis, Maternus-Kliniken AG (HAM:MAK) is currently considered Possible Value Trap. The stock's GF Value™ is €1.75, compared to a current price of €0.96 — trading 45.4% below its estimated fair value. The current Buyback Yield % is 0.00. Maternus-Kliniken AG's overall GF Score™ is 41/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Maternus-Kliniken AG (HAM:MAK), the current Buyback Yield % is 0.00 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Maternus-Kliniken AG (HAM:MAK) Overvalued in 2026?

Based on GuruFocus' analysis, Maternus-Kliniken AG stock appears to be undervalued. The current stock price of €0.96 is trading 45.4% below its estimated GF Value™ of €1.75. GuruFocus considers Maternus-Kliniken AG to be Possible Value Trap.

Key valuation signals for HAM:MAK:

  • Buyback Yield %: 0.00
  • GF Value™: €1.75 vs. price of €0.96 (45.4% below fair value)
  • GF Score™: 41/100 with 4 warning signs

No single metric tells the full story. See the HAM:MAK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Maternus-Kliniken AG Business Description

Other Exchanges 0N2K:UKMAK:Germany
Address Strasse 53 - 55, Berlin, DEU, 10117
Maternus-Kliniken AG operates as a German healthcare company focused on senior housing, care facilities, and rehabilitation clinics.
41GF Score

Get the complete analysis for HAM:MAK

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.96
Price
€1.75
GF Value